Does Psyllium Satiety Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Psyllium Satiety Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - PEHM, containing 7.5% psyllium, was well-tolerated and compared to CHM, it significantly reduced the postprandial increase of participants' triglyceride ( p = 0.015), VLDL ( p = 0.015), and glucose levels ( p = 0.036). [Günal AM (2025); evidence level 2] - These findings suggest that psyllium enrichment of fast foods can help reduce risk factors for chronic diseases without compromising sensory quality. [Günal AM (2025); evidence level 2] - This study enriched hamburger meatballs (HM)-a popular low-fiber fast food-with psyllium, evaluated their sensory acceptability, and examined effects on postprandial lipidemia, glycemia, food intake, hunger, and satiety. [Günal AM (2025); evidence level 2] - HM containing 5% and 7.5% psyllium was first tested in a triple-blind sensory panel of 12 trained dietitians; no significant differences in preference or hedonic scores ( p > 0.05) supported 7.5% as suitable for further trials. [Günal AM (2025); evidence level 2] - In particular, it may be effective in the management of conditions such as hypertension, diabetes, and liver disease, alongside other potential health benefits, such as its ability to support gastrointestinal health, cardiovascular risk reduction, and metabolic control. [Sanlier Nevin (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.